Buy Semax 30 mg in Australia
Semax 30 mg is a research-grade peptide that is studied in neuroprotection research, supplied in Australia by Australian Research Peptides to laboratories and researchers. It is the larger of two strengths ARP lists. The 30 mg vial is independently lab-tested; no certificate is published for it yet. Semax is a short laboratory-made peptide based on a fragment of a natural hormone. This 30 mg vial costs $139.99 and is out of stock today; ARP ships from within Australia to all states and territories. For in vitro research purposes only.
Neuropeptide Research · Lyophilised Powder · Independently lab-tested · SKU 26462
10 mg30 mg
$139.99
Presentation
30 mg per vial
Grade
Research Grade
Form
Lyophilised Powder
Category
Neuropeptide Research
This strength is not in stock — stocked lines dispatch same business day before 12pm Sydney time, Mon–Fri
Tracked shipping Australia-wide · typically 1–2 business days to most areas by Express Post · free post over $199, free Express over $299
For in vitro research purposes only. Not for human consumption. Not for animal consumption. This product is not a drug, food, cosmetic, or dietary supplement. No medical, therapeutic, or usage information is provided.
Browse all Neuropeptide Research
About Semax 30 mg
Seven amino acids long, it is a laboratory extension of a fragment of adrenocorticotropic hormone, and published papers file it both as ACTH(4-7)PGP and as an ACTH(4-10) analogue. This is the 30 mg Semax vial, the larger of two, listed as 26462.
Nothing is published for the 30 mg size yet — Semax lots are independently lab-tested, and the certificate follows.
In vitro neuroprotection research purposes only. Australian Research Peptides does not supply Semax for human or veterinary use.
Semax is studied in neuroprotection research, a field concerned with nerve-cell biology in culture and in animal models. The published literature on the compound is largely Russian-language and is built around which genes are active in brain tissue, most often those for nerve-growth proteins and for the Trk receptors they act on. Papers file the compound both as ACTH(4-7)PGP and as an analogue of ACTH(4-10). All of that work is preclinical, and none of it is a claim Australian Research Peptides makes for the vial.
Semax is a heptapeptide, which simply means a chain of seven amino acids. Written out it is Met-Glu-His-Phe-Pro-Gly-Pro, or MEHFPGP in single-letter code. The opening four are positions 4 to 7 of adrenocorticotropic hormone. The closing three, proline-glycine-proline, are synthetic, and the hormone does not carry them. Published papers file the compound both as ACTH(4-7)PGP and as an analogue of ACTH(4-10). Either way it is an analogue, so nothing proven about the hormone transfers to Semax.
Australian Research Peptides lists Semax under Neuropeptide Research, in a 10 mg and a 30 mg vial. Both hold the same chain and differ only in how much powder was weighed in. Its batches are independently lab-tested, by a laboratory the manufacturer commissions, before ARP sells them, and mass spectrometry confirms the mass matches a seven-amino-acid chain rather than the four-amino-acid fragment alone.
Further reading on Semax: Where Is the Best Place to Buy Peptides in Australia? · Semax vs Selank: What Is the Difference?
Semax 30 mg specifications, storage and shipping
- Compound: Semax
- Quantity: 30 mg
- SKU: 26462
- Presentation: sealed glass vial
- Form: Lyophilised Powder
- Grade: Research grade
- Testing: Independently lab-tested before release
- Identity confirmation: Mass spectrometry
- Classification: In vitro research purposes only — laboratory reference material
- Lyophilised — long term
- −20 °C to −80 °C — long-term storage
- Lyophilised — short term
- 2–8 °C — refrigerated, for a few months
- Reconstituted
- 2–8 °C — use within 8–12 weeks
Semax is independently lab-tested before release. No laboratory report is published for this strength yet. The COA library lists every product and strength, and says which reports are available.
This strength is not in stock today. Stocked lines ordered before 12pm Sydney time on a business day are dispatched the same day with tracked shipping. Standard delivery within Australia typically takes 2–5 business days. See Shipping & Delivery for details, and follow your parcel on the Track Order page.
For in vitro research purposes only. Not for human consumption. Not for animal consumption. Not a drug, food, cosmetic, or dietary supplement. No therapeutic or medical claims are made.
Questions about Semax 30 mg
This Semax 30 mg question guide from Australian Research Peptides is specific to the exact listing, with live buying details, size comparisons, concentration calculations, storage, testing and the inherited product background grouped separately. Start with the quick answers or jump to the topic you need.
Exact strength, quantity and listing fit
Three 10 mg Semax vials cost $197.97; one 30 mg vial is $139.99 — $57.98 less, and two fewer vials to store.
Per milligram, Semax 30 mg works out to about $4.67 — $139.99 across 30 mg. The 10 mg Semax vial works out to about $6.60 a milligram.
A 30 mg Semax vial contains thirty milligrams of dry Semax under one seal — three times the smaller listing's fill and the larger of the two listed sizes. Same lyophilised powder, same sealed glass, same absence of any supplied diluent.
The 30 mg Semax vial suits sustained or repeated work where one continuous supply beats opening a new vial at every stage and the larger fill's lower per-milligram rate is worth the bigger single commitment up front.
Live price, stock and Australian buying
Australian Research Peptides (ARP) sells Semax 30 mg in Australia under 26462, at $139.99. Standard tracked post and Express Post carry Semax 30 mg to all states and territories.
Semax 30 mg is $139.99 a vial (26462). Two 30 mg vials come to $279.98.
Not on its own. Semax 30 mg is $139.99, $59.01 under $199. Semax clears it with two 30 mg vials. Semax's 10 mg vial falls short too.
$152.98 delivered in Australia. Semax 30 mg is $139.99, plus $12.99 for 26462 by Standard tracked post. Express Post makes 26462 $156.98.
Three vials of Semax. At $139.99 each, three 30 mg vials make $419.97 — past $299, so 26462 ships free by Express Post, costing $419.97.
Reconstitution and concentration calculations
Australian Research Peptides publishes no fill volume for 26462, so the amount is a decision for the work rather than one the listing sets. 26462 is 30 mg of dry Semax: what the diluent changes is the solution, never the 30 mg sealed in the glass.
A 30 mg Semax vial places thirty milligrams under one seal, replacing three separate 10 mg vials, three make-ups and three lots. Each Semax page prints its own per-milligram figure, so the money side compares without doing the sum by hand.
Product identity and research background
Semax is a synthetic peptide of seven amino acids — four of them a fragment of adrenocorticotropic hormone, the other three a laboratory-added tail. That fragment was chosen because it carries none of the parent hormone's hormonal activity. Semax was developed in Moscow and is studied in cognition and neuroprotection research, largely in Russian-language literature.
Semax is described in molecular terms rather than by outcome. It is an analogue of the ACTH(4-7) fragment, and the literature examines it against neurotrophin gene transcription — BDNF, nerve growth factor and their Trk receptors — in brain tissue (Stavchansky 2011). The compound is not a hormone: the synthetic Pro-Gly-Pro tail replaces the residues carrying the parent's corticotropic activity. Every measurement reported for it is preclinical.
Research on Semax is preclinical and largely Russian-language, and it sits in two named areas: neuroprotection and cognition. The endpoints are molecular — transcription of neurotrophin genes and their receptors, and markers of intracellular signalling in brain tissue. Nothing in that literature goes beyond those model systems, and Australian Research Peptides makes no claim for the compound beyond its identity and its assay.
Australian Research Peptides supplies Semax as one freeze-dried solid in a sealed vial. That solid is the chain MEHFPGP, at the milligram weight printed on the label. The powder runs white to off-white inside sealed, tamper-evident glass. There is no filler, no carrier, no second peptide and no liquid. Four of the seven amino acids reproduce part of adrenocorticotropic hormone, and the closing proline-glycine-proline is added in the lab.
Semax is short-lived in serum, and no clean stability figure has been printed for it. Chromatographic work on the peptide in serum describes aminopeptidase — an enzyme that trims amino acids off the front of a chain — removing the first two and leaving shorter fragments of the same chain. Methionine sits at the front of Semax and is the amino acid most exposed to that, which is also why the dry powder is kept sealed, cold and dark rather than held in solution.
Semax is built from seven amino acids in one chain, which makes it a heptapeptide. In order they are Met-Glu-His-Phe-Pro-Gly-Pro, shortened to MEHFPGP (PubChem). Met-Glu-His-Phe is a stretch of adrenocorticotropic hormone, positions four through seven. The last three are a synthetic addition the hormone itself does not have. The count of seven belongs to Semax itself, so both vial sizes contain the identical chain.
Semax has an unusually long paper trail for a research peptide: it has been a registered product in Russia since 1994 and carries decades of Russian-language literature behind it. That record has not been reproduced in Western work, which is the main reason the compound remains unfamiliar elsewhere. Australian Research Peptides supplies it as a research chemical and makes no claim about what it does.
Storage, condition and testing
Most cloudy Semax reports come down to bubbles worked in during mixing, and they lift out within minutes of the vial being set down. The thirty-milligram strength dissolves more slowly than the ten, having three times as much material to take up, so patience beats extra agitation. Once warmed and rested a proper preparation is clear; lasting milkiness or floating specks are not normal.
Semax is dissolved in an aqueous diluent, because the vial contains dry peptide and nothing wet. Diluent is the standard term for whatever a dry compound dissolves into. Semax comes in two vial sizes, both equally dry, so each vial is dissolved on its own.
Semax and Selank are different molecules that share one feature. Both are seven-amino-acid chains ending in proline-glycine-proline, but their opening four amino acids come from unrelated parents. Semax opens with a fragment of adrenocorticotropic hormone. Selank opens with tuftsin. The research fields differ too: Semax is studied for neuroprotection, Selank for signalling between nerve cells and for inflammation-linked genes. Neither substitutes for the other.
Delivery, payment and access questions
Semax is also known as ACTH(4-7)PGP (Sudarkina 2021), as MEHFPGP in single-letter code, and by its written sequence Met-Glu-His-Phe-Pro-Gly-Pro; some papers file it as an analogue of ACTH(4-10) (Eremin 2005). Replacing the last three amino acids with Pro-Gly-Pro is what strips out the hormone action that ACTH carries, so it is an analogue, a modified copy, rather than a piece of ACTH itself. N-Acetyl Semax and the amidated version are related molecules with their own database records, not alternative names. Whichever term you typed, the vial ships from Australian Research Peptides, warehoused locally and independently lab-tested, with the CoA library showing where a certificate is already published.
More questions
Semax comes in two quantities and they look markedly different. Ten milligrams leaves a faint dusting easily read as an empty container; thirty milligrams is three times as much solid and forms a properly visible cake. Neither holds a bulking agent, so what sits inside the glass is peptide alone. Comparing the two strengths explains most confusion about the smaller one.
Store the sealed Semax vial frozen, dry and out of the light. GenScript flags cysteine, methionine and tryptophan as prone to oxidation, and Semax opens with a methionine, which is why light and air matter. Bachem keeps freeze-dried peptides below minus 15 degrees Celsius in a closed container, and GenScript's own figure is minus 20, away from bright light. Warm a frozen vial fully before you break the seal, so moisture does not condense inside. Peptide in solution is far less stable than the dry powder.
Semax in solution is refrigerated at 2 to 8 degrees and given a life of eight weeks to twelve by Australian Research Peptides' published condition. Semax opens on a methionine — MEHFPGP places the most oxidation-prone residue first, at an unblocked N-terminus — so light and dissolved air deserve as much attention as the calendar. The 30 mg vial is likelier to outlast that window.
Semax has never been approved in the United States. It is approved somewhere, however: Russia's health ministry registered it as a medicine in 1994. A registration granted in one country is not a worldwide licence, and no Western agency has assessed the Russian-language clinical record standing behind it. Freeze-dried research powder is not that registered product in any case.
Semax has no listing of its own in any prohibited category. Whether the residual S0 heading reaches it turns on one point: Russia's health ministry registered Semax as a medicine in 1994, and S0 excludes anything a government regulator has approved somewhere. Whether an anti-doping panel accepts a Russian registration is untested, so Australian athletes should ask Sport Integrity Australia.
Semax is independently lab-tested before supply, with mass spectrometry reading the molecular mass and comparing it against what the sequence predicts. For Semax that check matters, because it separates a seven-amino-acid chain from the shorter ACTH(4-7) fragment it opens with. No matching certificate is currently published for this product and strength.
Plain Semax is not the same as N-Acetyl Semax Amidate. Australian Research Peptides supplies plain Semax, unmodified at both ends of the chain, with a free amino group at one end and a free acid at the other. N-Acetyl Semax Amidate carries an acetyl group at one end and an amide at the other, changes intended to alter stability. It is a different molecule with a different molecular formula, held as a separate record in the public databases, and suppliers do not always make the distinction clear. ARP states which of the two it supplies in its published specifications.
Semax and Selank come from the same Russian research programme but derive from different parents — Semax from an ACTH fragment, Selank from tuftsin — and their published literatures sit in different research areas, Semax in neuroprotection and Selank in nerve-cell signalling and inflammation-linked gene expression. They are complementary rather than competing, which is why researchers frequently hold both.